122 related articles for article (PubMed ID: 10337001)
21. Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death.
Aringer M; Feierl E; Steiner G; Stummvoll GH; Höfler E; Steiner CW; Radda I; Smole JS; Graninger WB
Lupus; 2002; 11(2):102-8. PubMed ID: 11958572
[TBL] [Abstract][Full Text] [Related]
22. Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.
Aderka D; Sorkine P; Abu-Abid S; Lev D; Setton A; Cope AP; Wallach D; Klausner J
J Clin Invest; 1998 Feb; 101(3):650-9. PubMed ID: 9449699
[TBL] [Abstract][Full Text] [Related]
23. Role of neutrophils in release of some cytokines and their soluble receptors.
Jablonska E; Jablonski J; Holownia A
Immunol Lett; 1999 Dec; 70(3):191-7. PubMed ID: 10656673
[TBL] [Abstract][Full Text] [Related]
24. Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barré syndrome.
Créange A; Bélec L; Clair B; Raphaël JC; Gherardi RK
J Neuroimmunol; 1996 Aug; 68(1-2):95-9. PubMed ID: 8784265
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection.
Marinos G; Naoumov NV; Rossol S; Torre F; Wong PY; Gallati H; Portmann B; Williams R
Gastroenterology; 1995 May; 108(5):1453-63. PubMed ID: 7729638
[TBL] [Abstract][Full Text] [Related]
26. Early detection of increased tumour necrosis factor alpha (TNFalpha) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course.
Spielmann S; Kerner T; Ahlers O; Keh D; Gerlach M; Gerlach H
Acta Anaesthesiol Scand; 2001 Mar; 45(3):364-70. PubMed ID: 11207475
[TBL] [Abstract][Full Text] [Related]
27. [Role of the TNF system in the pathomechanism of bronchial asthma].
Halász A; Cserháti E; Cseh K
Orv Hetil; 2002 Mar; 143(11):553-7. PubMed ID: 12583324
[TBL] [Abstract][Full Text] [Related]
28. Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis.
Shimizu T; Tomita Y; Son K; Nishinarita S; Sawada S; Horie T
Clin Rheumatol; 2000; 19(5):352-9. PubMed ID: 11055823
[TBL] [Abstract][Full Text] [Related]
29. Increased soluble tumor necrosis factor receptor expression and release by human immunodeficiency virus type 1 infection.
Kalinkovich A; Geleziunas R; Kemper O; Belenki D; Wallach D; Wainberg MA; Bentwich Z
J Interferon Cytokine Res; 1995 Sep; 15(9):749-57. PubMed ID: 8536102
[TBL] [Abstract][Full Text] [Related]
30. Evidence for control of tumour necrosis factor-alpha (TNF-alpha) activity by TNF receptors in patients with proliferative diabetic retinopathy.
Limb GA; Soomro H; Janikoun S; Hollifield RD; Shilling J
Clin Exp Immunol; 1999 Mar; 115(3):409-14. PubMed ID: 10193411
[TBL] [Abstract][Full Text] [Related]
31. Both serum receptors of tumor necrosis factor are influenced by mud pack treatment in osteoarthrotic patients.
Bellometti S; Galzigna L; Richelmi P; Gregotti C; Bertè F
Int J Tissue React; 2002; 24(2):57-64. PubMed ID: 12182234
[TBL] [Abstract][Full Text] [Related]
32. Tumour necrosis factor-alpha (TNF), lymphotoxin and TNF receptor levels in serum from patients with Wegener's granulomatosis.
Jónasdóttir O; Petersen J; Bendtzen K
APMIS; 2001 Nov; 109(11):781-6. PubMed ID: 11900058
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
Galve-de Rochemonteix B; Nicod LP; Dayer JM
Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
[TBL] [Abstract][Full Text] [Related]
34. Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with bulimia nervosa.
Nakai Y; Hamagaki S; Takagi R; Taniguchi A; Kurimoto F
Clin Endocrinol (Oxf); 2000 Sep; 53(3):383-8. PubMed ID: 10971457
[TBL] [Abstract][Full Text] [Related]
35. Clinical implications of serum levels of soluble CD23 and tumor necrosis factor alpha in low-grade non-Hodgkin's lymphoma.
Zinzani PL; Baccini C; Zaccaria A; Visani G; Buzzi M; Morelli A; Molinari AL; Salvucci M; Bendandi M; Rubboli D; Gherlinzoni F; Zanchini R; Tura S
Eur J Haematol; 1996 Nov; 57(5):335-40. PubMed ID: 9003473
[TBL] [Abstract][Full Text] [Related]
36. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
Jabłońska E; Pietruska Z
Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):449-53. PubMed ID: 9437501
[TBL] [Abstract][Full Text] [Related]
37. [Serum tumor necrosis factor-alpha levels in non-Hodgkin's lymphoma patients and its relationship to prognosis].
Li D; Li G; Wang B
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):293-6. PubMed ID: 11038763
[TBL] [Abstract][Full Text] [Related]
38. Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection.
Weiss M; Martignoni M; Petropoulou T; Sölder B; Belohradsky BH
Infection; 1996; 24(4):301-8. PubMed ID: 8875282
[TBL] [Abstract][Full Text] [Related]
39. Resistance training enhances insulin-mediated glucose disposal with minimal effect on the tumor necrosis factor-alpha system in older hypertensives.
Reynolds TH; Supiano MA; Dengel DR
Metabolism; 2004 Mar; 53(3):397-402. PubMed ID: 15015154
[TBL] [Abstract][Full Text] [Related]
40. Peripheral natural killer cell activity and intraperitoneal soluble p55 tumor necrosis factor receptor in patients with malignant ascites: two possible indicators for response to intraperitoneal combined tumor necrosis factor alpha and interferon gamma treatment.
Ott MG; Männel DN; Gallati H; Goerig M; Raeth U
Cancer Immunol Immunother; 1996 Jan; 42(1):31-7. PubMed ID: 8625364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
